DPHARMA

1.460

+0.04 (+2.8%)

Change in Principal Officer

DUOPHARMA BIOTECH BERHAD

Date of change	01 Dec 2025
Name	ENCIK WAN AMIR-JEFFERY BIN WAN ABDUL MAJID
Age	53
Gender	Male
Nationality	Malaysia
Type of change	Appointment
Designation	Group Chief Executive Officer

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
	Degree	Bachelor of Business Administration - International Trade	University of Central Arkansas, United States of America
	Others	Senior Management Development Program	Harvard Business School, United States of America
	Others	Qualified Risk Director (QRD)	Institute of Enterprise Risk Practitioners

Working experience and occupation

Past Appointments/Experiences:
-Executive Director, Resources Management (SRM) Sdn Bhd from 1997 to 2007
-Lead Business Analyst, Biomedical Business Development and Investment Division, Malaysian Biotechnology Corporation (BiotechCorp) Sdn Bhd from 2007 to 2008
-Vice President, Biomedical Business Development and Investment Division, Malaysian Biotechnology Corporation (BiotechCorp) Sdn Bhd from 2008 to 2013
-Chief Executive Officer, Johor Biotechnology & Biodiversity Corporation and J-Biotech Holdings Sdn. Bhd from 2013 to 2016
-Chief Strategy Officer, Duopharma Biotech Berhad from 2016 to 2018
-Chief Operating Officer, Duopharma Biotech Berhad from 2018 to 2020
-Chief Commercial Officer, Duopharma Biotech Berhad from 2020 to 2022
-Chief Executive Officer - Commercial, Duopharma Biotech Berhad from 2022 to 2024

Other Current Appointment(s):
-Member, Duopharma Biotech's Group Management Committee
-Board Member, INTI University Advisory Board 
-Vice-President, Malaysian Organisation of Pharmaceutical Industry (MOPI).

Directorships in public companies and listed issuers (if any)

None

Family relationship with any director and/or major shareholder of the listed issuer

None

Any conflict of interests that he/she has with the listed issuer

None

Details of any interest in the securities of the listed issuer or its subsidiaries

None

Remarks :

Pursuant to the Succession Plan of Duopharma Biotech Berhad, Encik Wan Amir-Jeffery Bin Wan Abdul Majid, the current Group Chief Executive Officer, takes over from Encik Leonard Ariff Bin Abdul Shatar, the Group Managing Director, as the chief executive, i.e., the principal executive officer of Duopharma Biotech Berhad.

Announcement Info

Company Name	DUOPHARMA BIOTECH BERHAD
Stock Name	DPHARMA
Date Announced	28 Nov 2025
Category	Change in Principal Officer
Reference Number	C04-18072025-00001

View original announcement